Viemed Healthcare, Inc.: stock overview

VMDNASDAQHealthcare · Services-Misc Health & Allied Services, NEC

Price

$9.17

November 13, 2026Market cap $354M

DCF calculator

What Ploutos Investor adds for Viemed Healthcare

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 8 fiscal years, from 2018
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

In short

Viemed Healthcare had revenue of $310M over the last 12 months and net income of $16M, a net margin of 5.0%. Revenue grew by 15.5% a year on average over the last 5 years. At $9.17 the shares trade at a P/E of 22.7, against a median of 28.6 over the last 5 fiscal years. It holds more cash than debt, by $4.7M. It pays no dividend.

From its SEC filings (latest fiscal year to December 31, 2025) and the price of November 13, 2026.

Its SEC filings
Market cap
$354M
38.60M shares
P/E
22.7
Today22.7
Median28.6
Revenue, 12 months
$310M
+15.5% a year over 5 years
Net margin
5.0%
2025: 5.7%, above 74% of its industry

Worth knowing

What a holder would want to hear from the company's SEC filings of the last three years. Each with its filing, without comment.

3 fiscal years in figures

Each fiscal year's figures as the company filed them, and the share price at its end.

2023–2025 fiscal years

+21.5% a year over 2 years

  • 202510-K
    Revenue$270M
  • 202410-K
    Revenue$224M
  • 202310-K
    Revenue$183M

Fiscal years in figures

VMD's revenue, profit, cash flow and dividend with each year-end price, from 2018 to 2022, 5 more fiscal years

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 5 fiscal years.

Key figures

The company's current figures in five groups. Each term is explained behind its ⓘ.

Valuation

Market cap 3-year median: $304M
$354M
Enterprise value 
$349M
P/E 3-year median: 28.6
22.7
EV / EBIT 
14.5
EV / Revenue 
1.1
P/B 3-year median: 2.4
2.4
FCF yield 3-year median: 4.2%
6.0%
Earnings yield 3-year median: 3.5%
4.4%

Profitability

Gross margin 
57.4%
Operating margin 
7.8%
Net margin 3-year median: 5.5%
5.0%
ROIC 
11.1%
ROIC, 5-year average 
9.5%
ROE 
11.0%

Growth

Revenue, yearly change 
+20.5%
EPS, yearly change 
+32.1%
FCF, yearly change 
+805.2%
Revenue, average a year 
+15.5%
EPS, average a year 
-13.9%

The yearly change compares FY2025 with FY2024.

Balance sheet

Cash 
$9.7M
Total debt 
$9.3M
Of which operating leases 
$4.3M
Net cash 
$4.7M
Net debt / EBITDA 
-0.1x
Interest cover 
–
Current ratio 
1.25

Balance sheet of September 30, 2026.

Returns to shareholders

Dividend yield 
0.00%
Buybacks 
3.74%
Total returned 
3.74%
Shares, yearly change 
-2.3%
Valuation against its own pastEach fiscal year's P/E, P/FCF and P/B beside today's, and the DCF calculator for the company.Valuation

Against its industry

Where its margins and returns stood in fiscal 2025 among the SEC filers of its industry (SIC code 80).

Gross margin

57.5%

Above 58% of the 25 companies in its industry, and 76% of all.

Operating margin

8.5%

Above 73% of the 62 companies in its industry, and 61% of all.

Net margin

5.7%

Above 74% of the 68 companies in its industry, and 54% of all.

ROE

10.9%

Above 70% of the 58 companies in its industry, and 63% of all.

ROA

7.7%

Above 85% of the 69 companies in its industry, and 82% of all.

Revenue growth

20.5%

Above 71% of the 68 companies in its industry, and 82% of all.

From the yearly figures every company files with the SEC, for those with revenue of at least $25 million. The industry is the first two digits of the SIC code.

The company at the SEC

How it is registered and when its fiscal year ends.

Name at the SEC
VIEMED HEALTHCARE, INC.
CIK
1729149
Exchange
NASDAQ
Industry (SIC)
8090 · Services-Misc Health & Allied Services, NEC
Fiscal year ends
December 31
Latest annual report
December 31, 2025
Reporting currency
USD
Shares
38.60M

Other companies: Healthcare

The largest companies of the same sector, each with its own page.

The Healthcare sectorAll companies

The full analysis

What do Viemed Healthcare's filings show?

These are Viemed Healthcare's figures. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

Questions about VMD

Didn't find what you were looking for?

Ask us
What is VMD's market cap?

Viemed Healthcare, Inc.'s market cap is $354M, at a price of $9.17 on November 13, 2026 and 38.60M shares.

What is VMD's P/E?

VMD's P/E is 22.7, on earnings per share of $0.38 over the last 12 months. The median over the last 5 fiscal years was 28.6.

How much revenue does VMD have?

Viemed Healthcare had revenue of $310M over the last 12 months. Over the last 5 years it changed by +15.5% a year on average.

Does VMD pay a dividend?

No. Viemed Healthcare paid no regular dividend over the last 12 months.

Where do the figures come from?

From Viemed Healthcare, Inc.'s SEC filings (10-K and 10-Q) and the share price. They hold no analyst estimates and no score, and they are not a recommendation.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

US stocksThe market today, the sectors, the largest companies and the week's results.The market's sectorsThe 11 sectors side by side: returns, share of the market, median P/E and dividend.Compare stocksTwo companies side by side: price over up to ten years, with and without dividends, and every figure.US dividend stocksEach dividend's yield next to whether the company's cash covers it and whether it was ever cut.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.